You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國生物製藥(01177.HK)苯磺順阿曲庫銨注射液獲藥品註冊證書
格隆匯 12-28 16:42

格隆匯12月28日丨中國生物製藥(01177.HK)公佈,集團開發的肌松藥苯磺順阿曲庫銨注射液(商品名:得泰安)已獲中國國家藥品監督管理局頒發藥品註冊證書,且視同通過仿製藥質量和療效一致性評價,為該品種國內首批通過一致性評價。

苯磺順阿曲庫銨注射液為強效、中時效、非去極化肌松藥,兼有穩定心血管的特點,適用於各種外科手術中全身麻醉期間的骨骼肌鬆弛,也適用於氣管插管時所需的肌肉鬆弛。苯磺順阿曲庫銨應用範圍廣,在不同病人間藥代學差異小,無肝腎損害,安全性好,適於老年、兒童、心臟和肝腎功能異常等特殊患者以及重症加強護理病房(ICU)病人,是較為理想的一款肌松藥。

得泰安的獲批將進一步增強集團在手術麻醉領域上的產品佈局,獲批通過一致性評價將可為廣大患者帶來質量療效可靠的新用藥選擇。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account